Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00659659 · ClinicalTrials.gov registry record · Phase 1
A Study to Evaluate the Safety, Tolerability and Effects of MEDI-563 in Adults With Asthma
A Phase 1 study, sponsored by MedImmune.
- Completed
- Registry status
- Phase 1
- Development phase
- 27
- Enrollment target
NCT00659659 is a Phase 1 study that has completed, run by MedImmune. The registered enrollment target is 27 participants.
The verdict
NCT00659659, a Phase 1 study, has completed, sponsored by MedImmune.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 27 participants
- Enrollment target
Study Summary
Evaluate the safety and tolerability of MEDI-563 in adults with asthma and the effects of MEDI-563 on eosinophil counts in airway mucosal biopsies
Interventions
- OTHER Placebo
- DRUG MEDI-563
- OTHER Placebo Comp.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2008-01 |
| Est. Completion | 2011-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00659659
The ClinicalTrials.gov registry entry for NCT00659659 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MedImmune, which has 210 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00659659 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00659659 about?
NCT00659659 is a clinical study titled "A Study to Evaluate the Safety, Tolerability and Effects of MEDI-563 in Adults With Asthma". Evaluate the safety and tolerability of MEDI-563 in adults with asthma and the effects of MEDI-563 on eosinophil counts in airway mucosal biopsies
What is the current status of trial NCT00659659?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 27 participants. The study started on 2008-01. Estimated completion is 2011-03.
What interventions are being tested in trial NCT00659659?
The interventions under investigation include: Placebo (OTHER), MEDI-563 (DRUG), Placebo Comp. (OTHER).
Who is sponsoring clinical trial NCT00659659?
This trial is sponsored by MedImmune, which has 210 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.